The complexity of surgical decision making for breast cancer has markedly increased in recent years. Most women with early breast cancer currently are eligible for two general surgical treatment choices: mastectomy or breast-conserving surgery (plus radiation therapy). The patients who undergo mastectomy must further decide whether to undergo no reconstruction, immediate reconstruction, or delayed reconstruction.
The patients who undergo reconstruction must decide whether to undergo nipple-sparing mastectomy, must choose from a variety of different reconstruction options, and must consider management strategies for their contralateral breast. To complicate the process further, those patients for whom chemotherapy is recommended (patients with estrogen receptor-negative or HER2? breast cancer), must decide whether to receive pre-or postoperative chemotherapy. Because the oncologic outcomes of all these various options are equivalent, determination of patient preference and satisfaction is extremely important.
In their article, Atisha and colleagues evaluate breast satisfaction scores from a large cohort of women who underwent breast cancer surgery using a validated survey instrument. The authors report that women with early-stage breast cancer treated with mastectomy and deep tissue reconstruction are more satisfied with their breasts than women who undergo breast-conserving therapy, mastectomy alone, or mastectomy with reconstruction using implants. Because the survival rates are identical for these procedures, the authors suggest that a focus on patient preferences should help direct how physicians counsel patients. However, measuring patient satisfaction after breast surgery is quite complicated. Long-term breast satisfaction is only one important measurement. The clinician also must consider early outcomes after surgery including personal costs, pain and discomfort, need for unplanned surgical procedures, and return to preoperative physical activities. These outcomes were not reported in the accompanying article. Furthermore, breast reconstruction is associated with significantly higher complication rates than those for either breast-conserving surgery or mastectomy alone. 1 Unfortunately, the current study by Atisha and colleagues actually removed patients who experienced complications from their original treatment group and placed them in a separate category. This methodology certainly biases the results in favor of the treatment groups that otherwise would have had a greater number of complications.
In addition to cosmetic and body image outcomes, other important long-term patient satisfaction measures must be considered including overall adjustment to illness, satisfaction with relationships, sexual well-being, fear of recurrence, and chronic pain. Measurement of patient satisfaction also is a time-dependent variable: generally, the longer the time elapsed since surgery, the greater the feelings of psychological adjustment. 2 On the other hand, Atisha and colleagues reported that breast satisfaction scores were significantly lower with increased time since surgery, further illustrating the complicated nature of this issue.
Multiple studies have demonstrated that patient satisfaction after breast cancer surgery is strongly associated with the initial decision-making process. 3 For many decades, the predominant model of surgical decision making was paternalistic and driven by the physician's expertise. Often, the patient's involvement was reduced to consenting to the proposed treatment. In the past, many surgeons used a one-stage biopsy-mastectomy approach that involved general anesthesia, open surgical biopsy, frozen section, and then mastectomy and axillary lymph node dissection. The paternalistic model did not permit bidirectional communication between surgeon and patient.
Interestingly, the pendulum has now swung dramatically the other direction toward a consumerism-dominant model. Consider the patient with stage 1 breast cancer who requests bilateral nipple-sparing mastectomies with deep inferior epigastric perforator (DIEP) reconstruction for ''peace of mind.'' At the extreme of the consumerismdominant model, patients direct the care, and the physicians carry out their orders for the sake of patient-centered care but at the expense of evidence-based medicine.
At the time of diagnosis and while considering surgical treatment options, breast cancer patients express high levels of anxiety. Furthermore, the decision-making process usually is condensed into the first few weeks after diagnosis, which only adds to the anxiety level. In an editorial on contralateral prophylactic mastectomy, Katz and Morrow 4 conclude that virtually all breast cancer treatments that confer lifetime benefits are initiated within the first few months after diagnosis. Frequently, breast cancer patients make quick and pressured decisions on surgical treatments that have irreversible consequences and potential side effects. Additionally, recent studies have demonstrated that breast cancer patients often have substantially inaccurate perceptions of recurrence risk and expected outcomes from surgical treatments. 5, 6 Therefore, physicians must identify and correct any misconceptions that patients may have during this very stressful period.
As is often true, the relationship between patient and physician should fall somewhere between the extremes of the paternalistic and consumerism models. In shared decision making, both partners share information about treatment options, take steps to reach a shared decision, and together arrive at a consensus.
A growing body of literature shows that shared decision making results in improved patient satisfaction. 3 As Atisha and colleagues astutely note in their article, women who choose mastectomy with reconstruction are more likely involved with the decision-making process, which may lead to increased satisfaction with their outcomes. In one population-based study, women who perceived that their surgeon made the decision alone had the lowest satisfaction scores. 3 On the other hand, patients tended to have regret when they reported more participation in the surgery decision than they desired. The decision-making process should ideally hit the sweet spot at which the patient shares her preferences and values and feels empowered about her decision, and the physician takes into account the patient's values but not at the expense of evidence-based care.
